- Home
- SVT vs BNR Comparison
SVT vs BNR Comparison
Compare SVT & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- BNR
- Stock Information
- Founded
- SVT 1959
- BNR 2014
- Country
- SVT United States
- BNR China
- Employees
- SVT N/A
- BNR N/A
- Industry
- SVT Industrial Machinery/Components
- BNR Medical Specialities
- Sector
- SVT Consumer Discretionary
- BNR Health Care
- Exchange
- SVT Nasdaq
- BNR Nasdaq
- Market Cap
- SVT 27.2M
- BNR 29.1M
- IPO Year
- SVT N/A
- BNR 2020
- Fundamental
- Price
- SVT $10.50
- BNR $2.61
- Analyst Decision
- SVT
- BNR
- Analyst Count
- SVT 0
- BNR 0
- Target Price
- SVT N/A
- BNR N/A
- AVG Volume (30 Days)
- SVT 6.2K
- BNR 55.0K
- Earning Date
- SVT 05-09-2025
- BNR 05-28-2025
- Dividend Yield
- SVT N/A
- BNR N/A
- EPS Growth
- SVT N/A
- BNR N/A
- EPS
- SVT N/A
- BNR N/A
- Revenue
- SVT $46,174,000.00
- BNR $70,669,261.00
- Revenue This Year
- SVT N/A
- BNR $136.32
- Revenue Next Year
- SVT N/A
- BNR N/A
- P/E Ratio
- SVT N/A
- BNR N/A
- Revenue Growth
- SVT 2.58
- BNR N/A
- 52 Week Low
- SVT $9.67
- BNR $2.18
- 52 Week High
- SVT $13.67
- BNR $8.99
- Technical
- Relative Strength Index (RSI)
- SVT 48.91
- BNR 36.21
- Support Level
- SVT $10.26
- BNR $2.30
- Resistance Level
- SVT $10.68
- BNR $2.78
- Average True Range (ATR)
- SVT 0.17
- BNR 0.28
- MACD
- SVT -0.01
- BNR 0.07
- Stochastic Oscillator
- SVT 34.78
- BNR 43.00
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users. Geographically, the company generates the majority of its revenue from the Domestic market.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.